中文 | English
Return
Total: 26 , 1/3
Show Home Prev Next End page: GO
Author:( Lisong WU)

1.Development and validation of a mortality risk prediction model for surgical treatment of myocardial infarction with ventricular septal rupture

Lisong WU ; Wei FU ; Ran DONG ; Jubing ZHENG

Chinese Journal of Clinical Thoracic and Cardiovascular Surgery 2026;33(05):759-765

2.Study on changes and correlations of color,components and anti-tumor activity of processed products of Gelsemium elegans at different sand-frying durations

Hao WU ; Lisong CHEN ; Chenglong HUANG ; Yueling WANG ; Lirong CHEN ; Wenyi WANG ; Yinghao WANG ; Desen LI ; Shuisheng WU ; Ying CHEN

China Pharmacy 2026;37(17):2258-2263

3.Ziyuglycoside II suppressed the progression of osteosarcoma by coordinating estrogen-related receptor gamma and p53 signaling pathway.

Hang DU ; Dongjin WU ; Tianyu ZHANG ; Ying ZHONG ; Kaiyi WU ; Xin GUO ; Lisong SHENG ; Nana HUANG ; Chunzheng GAO ; Rong SUN

Chinese Journal of Natural Medicines (English Ed.) 2025;23(3):354-367

4.To construct a perioperative risk prediction model for patients with coronary artery disease and heart failure with reduced ejection fraction undergoing surgical treatment based on cardiac magnetic resonance imaging

Kui ZHANG ; Kaiwen LIU ; Wei FU ; Hongkai ZHANG ; Jubing ZHENG ; Yiping SUN ; Lisong WU ; Taoshuai LIU ; Ran DONG

Chinese Journal of Thoracic and Cardiovascular Surgery 2025;41(1):22-29

5.To construct a perioperative risk prediction model for patients with coronary artery disease and heart failure with reduced ejection fraction undergoing surgical treatment based on cardiac magnetic resonance imaging

Kui ZHANG ; Kaiwen LIU ; Wei FU ; Hongkai ZHANG ; Jubing ZHENG ; Yiping SUN ; Lisong WU ; Taoshuai LIU ; Ran DONG

Chinese Journal of Thoracic and Cardiovascular Surgery 2025;41(1):22-29

6.Exploring the harm elimination model with regard to viral hepatitis C in China's western region

Xiao WU ; Yan YANG ; Qing CAO ; Lisong GAN ; Guohui WU ; Dachuan CAI

Chinese Journal of Hepatology 2024;32(S2):63-67

7.Exploring the harm elimination model with regard to viral hepatitis C in China's western region

Xiao WU ; Yan YANG ; Qing CAO ; Lisong GAN ; Guohui WU ; Dachuan CAI

Chinese Journal of Hepatology 2024;32(S2):63-67

8.Coronary angiographic characteristics of 997 patients with symptomatic recurrence after coronary artery bypass grafting

Xiaolong MA ; Jiangang WANG ; Ran DONG ; Haiming DANG ; Lisong WU ; Jian CAO ; Qingyu KONG ; Lin LIANG ; Wei XIAO ; Jiaji LIU ; Liqun CHI

Chinese Journal of Clinical Thoracic and Cardiovascular Surgery 2022;29(09):1156-1160

9.Study of quantitative flow ratio-guided surgical coronary artery revascularization strategy

Cong CHEN ; Yang ZHAO ; Kui ZHANG ; Pengyun YAN ; Haiming DANG ; Taoshuai LIU ; Yue SONG ; Jubing ZHENG ; Yang LI ; Lisong WU ; Jian CAO ; Ran DONG

Chinese Journal of Thoracic and Cardiovascular Surgery 2022;38(5):272-276

10.Assess grafts status in symptomatic patients with prior coronary artery bypass graft

Lisong WU ; Ran DONG ; Xiaolong MA ; Haiming DANG ; Yue SONG ; Jian CAO ; Dong LIU ; Qi HUANG

Chinese Journal of Thoracic and Cardiovascular Surgery 2020;36(8):498-501

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 26 , 1/3 Show Home Prev Next End page: GO